Delivery Order SPE2DB24D8002-SPE2DB25FJNSQ
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $16,170.78, is for the supply of Stelara 90 mg/mL syringes. The award is part of DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,085.39 contract is for the provision of STELARA 90 MG/ML syringes, a biologic medication used to treat autoimmune conditions. The award is under a larger single-award Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $19,196.40, is for the delivery of STELARA 90 MG/ML SYRINGEML medical supplies. The contract is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is under the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Stelara 90 mg/mL syringes, with a completion date of November 2, 2023, and a ceiling value of $8,600.28. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Stelara 90 mg/mL syringes. The total ceiling value of the award is $13,515.40, with a firm fixed price pricing type and an ultimate completion date of December 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, valued at...
This is a $18,921.34 firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the provision of Stelara 90 mg/mL syringes. The contract has an ultimate completion date of July 10, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA, supplying a wide range of pharmaceutical products, medical supplies, and healthcare equipment in...
This is a $12,846.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Stelara 90 mg/mL syringes. The contract has no set-aside designation and is awarded under DLA's pharmaceutical supply chain contracts to support medical supply operations for the U.S. Armed Forces. Dakota Drug, Inc. is an experienced prime contractor to DLA, specializing in providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML syringes. The $8,187.08 firm-fixed price award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00. This IDC allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,586.33, is for the provision of Stelara 90 mg/mL syringes, which are a biologic medication used to treat autoimmune conditions. The contract has an ultimate completion date of June 18, 2024 and was awarded on June 17, 2024. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of STELARA 90 MG/ML syringes. The contract has a ceiling value of $12,117.01 and a period of performance extending through November 13, 2024. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which enables the company to provide a comprehensive...